ctm
Castellum, Inc. Announces Pricing of $3.6 Million Registered Direct Offering
23 déc. 2024 06h50 HE | Castellum, Inc.
Castellum, Inc. Announces Pricing of $3.6 Million Registered Direct Offering
femasys logo 2.jpg
Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
08 oct. 2024 08h30 HE | Femasys Inc.
ATLANTA, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...
STRATA Skin Sciences Logo.jpg
STRATA Skin Sciences to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
08 oct. 2024 08h15 HE | STRATA Skin Sciences, Inc.
HORSHAM, Pa., Oct. 08, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and...
indaptus_logo.png
Indaptus Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
08 oct. 2024 08h00 HE | Indaptus Therapeutics
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will participate in a fireside chat at the...
CTMnew
Castellum Announces Closing of $2.7 Million Registered Direct Offering
29 janv. 2024 16h30 HE | Castellum, Inc.
Castellum, Inc. (the “Company”) (NYSE-American: CTM) closes on registered direct offering, consisting of the sale of 8,437,501 shares.
CTMnew
Castellum Announces Pricing of $2.7 Million Registered Direct Offering
25 janv. 2024 08h55 HE | Castellum, Inc.
Castellum, Inc. (the “Company”) (NYSE-American: CTM) has entered into a securities purchase agreement with an institutional investor to purchase 8,437,501
Atossa_Therapeutics_logo-min.png
Atossa to Participate in Fireside Chat at Healthcare Virtual Conference Presented by Maxim Group LLC
14 juin 2023 09h15 HE | Atossa Therapeutics, Inc.
SEATTLE, June 14, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant...
PALI.jpg
Palisade Bio (Nasdaq: PALI) to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group and Hosted by M-Vest
24 mars 2022 08h30 HE | Palisade Bio, Inc.
CARLSBAD, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI)...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference
15 mars 2021 08h00 HE | BioCardia, Inc.
SAN CARLOS, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, announces...
Zivo logo.jpg
ZIVO Bioscience to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference
11 mars 2021 12h25 HE | Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., March 11, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCQB: ZIVO), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic and...